Development and validation of an immunoassay for quantification of NCAM-1 in human plasma

被引:2
|
作者
Guven, Arcan [1 ]
Gray, Kayleigh [1 ]
Peng, Kuan-Wei [1 ]
Klotz, Allison [1 ]
Kellogg, Mark D. [1 ,2 ,3 ]
Narain, Niven R. [1 ]
Kiebish, Michael A. [1 ]
机构
[1] BERG, 500 Old Connecticut Path, Framingham, MA 01701 USA
[2] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA
[3] Boston Childrens Hosp, Dept Lab Med, 300 Longwood Ave, Boston, MA 02115 USA
关键词
NCAM-1; Biomarker; Assay development; Assay validation; Immunoassay; Ligand binding assay; NK CELL; CD56; LEUKEMIA; ANTIGEN; EXPRESSION;
D O I
10.1016/j.jpba.2021.113981
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Background: Neural Cell Adhesion Molecule 1 (NCAM-1), a multifunctional member of the immunoglobulin superfamily, is expressed on the surface of neurons, glia, skeletal muscle, and natural killer cells. NCAM-1 has been implicated as having a role in cell-cell adhesion, involved in development of the nervous system, and for cells involved in the expansion of T cells and dendritic cells which play an important role in immune surveillance. Sensitive and specific methods to quantify non-surface bound NCAM-1 are not available. Method: A sandwich ligand binding assay was developed for quantification of NCAM-1 in plasma and validated using an electro-chemiluminescent (ECL) technology. Results: The data presented here demonstrated that the validated method met all prespecified criteria for precision, linearity, and accuracy in the range of 62.5 ng/mL to 4000.0 ng/mL, the range believed to be most relevant for plasma. The bioanalytical validation of the assay established the inter-assay coefficient of variation <8 % for calibration points, <2 % for high quality control (HQC), <8 % for medium quality control (MQC) and <19 % for low quality control (LQC) samples. Purified NCAM-1 spike-recovery experiment in plasma was used to determine assay accuracy; nominal concentrations (%) of NCAM-1 ranged from 91 % to 112 % for high and low spike level, respectively. Assay performance was subsequently evaluated for parallelism, selectivity, interference, and stability. Conclusion: NCAM-1 assay has been developed and validated in human plasma and met all assay validation parameters pre-determined during development. Clinical testing of human plasma samples indicated that NCAM-1 does not seem to be influenced by age and was slightly influenced by gender. NCAM-1 assay has potential to be used as a biomarker assay once the assay is subjected to appropriate clinical assessment and diagnostic thresholds are established. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Analytical Validation of a Homogeneous Immunoassay for Determination of Mycophenolic Acid in Human Plasma
    Vergara Chozas, J. M.
    Saez-Benito Godino, A.
    Zopeque Garcia, N.
    Garcia Pinteno, S.
    Joumady, I.
    Carrasco Garcia, C.
    Vara Gil, F.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2669 - 2672
  • [42] NEURAL CELL ADHESION MOLECULE 1 (NCAM-1) IS ASSOCIATED TO LONG-TERM AVERSIVE MEMORY IN NEMATODES AND HUMANS
    Vukojevic, Vanja
    Mastrandreas, Pavlina
    Freytag, Virginie
    Elbert, Thomas
    Kolassa, Iris
    de Quervain, Dominique J. F.
    Papassotiropoulos, Andreas
    Stetak, Attila
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S852 - S852
  • [43] Development of a Sensitive Chemiluminescence Immunoassay for the Quantification of Folic Acid in Human Serum
    Chen, Xiang
    Zhou, Qiyang
    Zhang, Ting
    Wang, ChunXin
    Yu, Zheng
    Ahamada, Hadji
    Bai, Zhonghu
    Huang, Xuan
    JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY, 2019, 2019
  • [44] Cerebrospinal fluid NCAM-1 concentration is associated with neurodevelopmental outcome in post-hemorrhagic hydrocephalus of prematurity
    Limbrick, David D.
    Morales, Diego M.
    Shannon, Chevis N.
    Wellons, John C.
    Kulkarni, Abhaya, V
    Alvey, Jessica S.
    Reeder, Ron W.
    Freimann, Volker
    Holubkov, Richard
    Riva-Cambrin, Jay K.
    Whitehead, William E.
    Rozzelle, Curtis J.
    Tamber, Mandeep
    Oakes, W. Jerry
    Drake, James M.
    Pollack, Ian F.
    Naftel, Robert P.
    Inder, Terrie E.
    Kestle, John R.
    PLOS ONE, 2021, 16 (03):
  • [45] Development and validation of an UPLC method for the quantification of ethambutol in rat plasma
    Singh, Harinder
    Sharma, Gaurav
    Kaur, Indu Pal
    RSC ADVANCES, 2014, 4 (81): : 42831 - 42838
  • [46] Validation of a HPLC/FLD Method for Quantification of Tocotrienols in Human Plasma
    Che, Hui-Ling
    Tan, Doryn Meam-Yee
    Meganathan, Puvaneswari
    Gan, Yee-Lin
    Razak, Ghazali Abdul
    Fu, Ju-Yen
    INTERNATIONAL JOURNAL OF ANALYTICAL CHEMISTRY, 2015, 2015
  • [47] Development of an immunoassay for quantification of soluble human CD40L (CD154) in plasma and serum samples
    Pedersen, Kathrine
    Laursen, Nick Stub
    Hansen, Annette Gudmann
    Palarasah, Yaseelan
    Thiel, Steffen
    JOURNAL OF IMMUNOLOGICAL METHODS, 2024, 531
  • [48] Development and Validation of Liquid Chromatography-Tandem Mass Spectrometric Method for the Quantification of Diclofenac in Human Plasma
    Grover, Parul
    Bhardwaj, Monika
    Mehta, L.
    Kumar, Sandeep
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 (03) : 740 - 752
  • [49] Bioanalytical Method Development and Validation of HPLC-VU Method for Quantification of Embelin from Human Plasma
    Nijsure, Amey
    Vassa, Shwetal
    Jethawa, Shraddha
    Ghotpagar, Rohan
    Patil, Manali
    Mulgund, Sugandha
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY RESEARCH, 2024, 11 (03): : 299 - 307
  • [50] Development and validation of a bioanalytical LC-MS method for the quantification of GHRP-6 in human plasma
    Gil, Jeovanis
    Cabrales, Ania
    Reyes, Osvaldo
    Morera, Vivian
    Betancourt, Lazaro
    Sanchez, Aniel
    Garcia, Gerardo
    Moya, Galina
    Padron, Gabriel
    Besada, Vladimir
    Javier Gonzalez, Luis
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 60 : 19 - 25